Mr. John Gleeson:

If I could explain, when someone says to me that all women have been informed, one understands that "all women" refers to all women for whom we have communicated cytology reviews. This is an historical issue, and there are many historical cases. We were aware that some women had sadly passed away and that some letters - it is a continuous process - might have gone out yesterday and appointments were being set up to talk to the women. I was not aware of the full extent of difficulties being expressed with the open disclosure policy, alluded to by the Chair. I am sure they came to me in time, but at the time I was not aware at that time that Part 4 of the Civil Liability (Amendment) Act 2017 was about to be enacted to remove one of the barriers to open disclosure. I am sure I would have learned that.